About Proteovant Therapeutics
Proteovant Therapeutics is a company based in King Of Prussia (United States) founded in 2021 was acquired by SK in June 2023.. Proteovant Therapeutics operates in a competitive market with competitors including Freeline, Keros Therapeutics, Jasper Therapeutics, Disc Medicine and Accutar Biotechnology, among others.
- Headquarter King Of Prussia, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Proteovant Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Proteovant Therapeutics
Proteovant Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SK. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on energy, chemical, semiconductor, logistics, and multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Proteovant Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Proteovant Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Proteovant Therapeutics Comparisons
Competitors of Proteovant Therapeutics
Proteovant Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Freeline, Keros Therapeutics, Jasper Therapeutics, Disc Medicine and Accutar Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed to treat hematologic and musculoskeletal disorders.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for chronic diseases by targeting mast cells and stem cells
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of hematologic diseases
|
|
| domain | founded_year | HQ Location |
AI-assisted tools for drug discovery are developed.
|
|
| domain | founded_year | HQ Location |
Integrated chemistry service provider
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Proteovant Therapeutics
Frequently Asked Questions about Proteovant Therapeutics
When was Proteovant Therapeutics founded?
Proteovant Therapeutics was founded in 2021.
Where is Proteovant Therapeutics located?
Proteovant Therapeutics is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.
Who is the current CEO of Proteovant Therapeutics?
Drew Fromkin is the current CEO of Proteovant Therapeutics.
What does Proteovant Therapeutics do?
Proteovant Therapeutics was founded in 2021 and is headquartered in King of Prussia, United States. Therapies based on targeted protein degradation are developed for oncology and hematology indications. An AI-driven platform is employed to harness the ubiquitin-proteasome system, by which disease-associated proteins are identified and degraded through the bodys cellular processes. Operations focus on advancing these modalities within the biotechnology sector.
Who are the top competitors of Proteovant Therapeutics?
Proteovant Therapeutics's top competitors include Keros Therapeutics, Disc Medicine and Freeline.
Who are Proteovant Therapeutics's investors?
Proteovant Therapeutics has 1 investor. Key investors include SK.